H.C. Wainwright downgrades Day One Biopharmaceuticals to 'Neutral' on acquisition deal by ServierSee details
Day One Biopharma Inc - DAWN - stock price prediction, stock price target, analyst ratings from 8 analysts
Day One Biopharma Inc has a share price target of US$ 22, revenue growth forecast of 52.4%, and profit growth estimate of 24.7% for FY26, based on top 8 analyst calls.